Annals of Child Neurology10.26815/acn.2020.00059202028388-92Short Course and Early Switch of Vigabatrin for Infantile spasmsHye Won Ryu, Hunmin Kim, Byung Chan Lim, Hee Hwang, Jong-Hee Chae, Ji Eun Choi, Ki Joong Kim,,
Acta Neurologica Scandinavica10.1111/j.1600-0404.2011.01599.x201112436-47Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosingL. Carmant,
Epilepsia10.1046/j.1528-1157.2001.13501.x200142121580-1583Infantile Spasms in Down Syndrome: Good Response to a Short Course of VigabatrinR. Nabbout, I. Melki, B. Gerbaka, O. Dulac, C. Akatcherian,,,
Reactions Weekly10.1007/s40278-021-05962-92021188317-7Brain abnormalities after vigabatrin for infantile spasms,,
Pediatric Neurology10.1016/s0887-8994(98)00116-71999202106-110Vigabatrin in the treatment of infantile spasmsBetty Koo,
Pediatric Neurology10.1016/s0887-8994(02)00400-92002273161-164Vigabatrin for infantile spasmsWendy G Mitchell, Namrata S Shah,
Neuropsychiatric Disease and Treatment10.2147/ndt.s52352010731Clinical profile of vigabatrin as monotherapy for treatment of infantile spasmsRaman Sankar, Lerner, Salamon
Reactions Weekly10.1007/s40278-020-83350-1202018211230-230Vigabatrin,,
The Lancet10.1016/0140-6736(93)91255-k19933418850962Vigabatrin in infantile spasms—why add on?R.E. Appleton, F. Montiel-Viesca,
Epilepsy Currents10.5698/1535-7511-15.6.3272015156327-329Limiting Retinal Toxicity of Vigabatrin in Children with Infantile SpasmsPrakash Kotagal,,